Evaluation of the applicability of deep breathing test in the diagnosis of hypertension with white-coat effect in Chinese patients in primary care

키워드

참고문헌 (35)

1. Lim SS, "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010 : a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2224~2260 (2012)
2. Leung G, "Cohort profile : FAMILY cohort", Int J Epidemiol, 46(2), pp.e1~ (2015)
3. Collins R, "Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context", Lancet, 335, pp.827~838 (1990)
4. The Hypertension Detection and Follow-up Program Cooperative Group, "Five-year findings of the hypertension detection and follow-up program: I. reduction in mortality of persons with high blood pressure, including mild hypertension", JAMA, 242(23), pp.2562~ (1979)
5. Falaschetti E, "Continued improvement in hypertension management in England : results from the Health Survey for England 2006", Hypertension, 53(3), pp.480~ (2009)
6. Hajjar I, "Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000", JAMA, 290, pp.199~206 (2003)
7. Lloyd-Jones DM, "Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community", Hypertension, 36, pp.594~599 (2000)
8. Bunker J, "How common is true resistant hypertension?", J Hum Hypertens, 25(2), pp.137~140 (2010)
9. National Institute of Health and Clinical Excellence, "Hypertension: clinical management of primary hypertension in adults", NICE clinical guideline 127, ~ (2011)
10. O’Brien E, "Use and interpretation of ambulatory blood pressure monitoring : recommendations of the British hypertension society", BMJ, 320, pp.1128~1134 (2000)
11. Streitel KL, "Explaining gender differences in the white coat effect", Blood Press Monit, 16, pp.1~6 (2011)
12. MacDonald MB, "Prevalence and predictors of white-coat response in patients with treated hypertension", CMAJ, 161, pp.265~269 (1999)
13. de la Sierra A, "Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring", Hypertension, 57(5), pp.898~902 (2011)
14. Brown M, "Martin a. is resistant hypertension really resistant?", Am J Hypertens, 14(12), pp.1263~ (2001)
15. Myers MG, "The white coat effect in treated hypertension", Blood Press Monit, 1, pp.247~249 (1996)
16. Little P, "Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure", BMJ, 325, pp.254~259 (2002)
17. Myers MG, "White coat phenomenon in patients receiving antihypertensive therapy", Am J Hypertens, 4, pp.844~849 (1991)
18. Liana FL, "White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients : prevalence and target organ damage", J Diabetes, 7(5), pp.699~707 (2015)
19. Pierdomenico SD, "‘White-coat’ hypertension in patients with newly diagnosed hypertension : evaluation of prevalence by ambulatory monitoring and impact on cost of health care", Eur Heart J, 16, pp.692~697 (1995)
20. Huang CC, "Clinical predictors of significant white-coat effect in non-diabetic hypertensive patients", Acta Cardiol Sin, 26, pp.151~156 (2010)
21. Manios E, "Factors influencing White-coat effect", Am J Hypertens, 21(2), pp.153~158 (2008)
22. Redon J, "Prognostic value of ambulatory blood pressure monitoring in refractory hypertension : a prospective study", Hypertension, 31(2), pp.712~718 (1998)
23. White WB, "Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient", Blood Press Monit, 4(3–4), pp.181~184 (1999)
24. Parati G, "Difference between clinic and daytime blood pressure is not a measure of the white-coat effect", Hypertension, 31, pp.1185~1189 (1998)
25. Mancia G, "2013 ESH", ESC guidelines for the management of arterial hypertension : the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC), 2013, pp.34(28), 2159~2219
26. Staessen JA, "Participants of the 2001 consensus conference on ambulatory blood pressure monitoring. Task force II: blood pressure measurement and cardiovascular outcome", Blood Press Monit, 6, pp.355~370 (2001)
27. Mori H, "How does deep breathing affect office blood pressure and pulse rate?", Hypertens Res, 28, pp.499~504 (2005)
28. Bernardi L, "Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure", Circulation, 105, pp.143~145 (2002)
29. Augustovski FA, "The deep-breath test as a diagnostic maneuver for white-coat effect in hypertensive patients", J Am Board Fam Pract, 17, pp.184~189 (2004)
30. Tomičić M, "Deep breathing: a simple test for white coat effect detection in primary care", Blood Press, 24(3), pp.158~163 (2015)
31. Thalenberg JM, "Slow breathing test increases the suspicion of white-coat hypertension in the office", Arq Bras Cardiol, 91, pp.243~249 (2008)
32. Yoshihara K, "Deep breathing test(DBT)in predicting white coat hypertension", Fukuoka Igaku Zasshi, 84, pp.395~401 (1993)
33. Parati G, "Betaadrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients", Hypertension, 23(6 Pt 2), pp.992~996 (1994)
34. Niemelä M, "Effect of Beta-blockade on heart rate variability in patients with coronary artery disease", J Am Coll Cardiol, 23(6), pp.1370~ (1994)
35. Hajian-Tilaki K, "Sample size estimation in diagnostic test studies of biomedical informatics", J Biomed Info, 48, pp.193~204 (2014)

관련 논문AI추천